IP/C/R/TC/UNCTAD/3  
7 de septiembre  de 2022 
(22-6645) Página: 1/8 
Consejo de los Aspectos de los Derechos de Propiedad 
Intelectual relacionados con el Comercio  Original:  inglés  
 
  
ACTIVIDADES DE COOPERACIÓN TÉCNICA: INFORMACIÓN FACILITADA  
POR OTRAS ORGANIZACIONES INTERGUBERNAMENTALES  
CONFERENCIA DE LAS NACIONES UNIDAS SOBRE COMERCIO Y DESARROLLO (UNCTAD)  
En la reunión celebrada el 6 de julio de 2022, el Consejo de los ADPIC acordó invitar a las 
organizaciones intergubernamentales acreditadas como observadoras ante el Consejo a que 
actualizaran la información sobre sus programas de cooperación técnica y fin anciera relacionados 
con la aplicación del Acuerdo sobre los ADPIC.  
En el presente documento se reproduce la información recibida de la Conferencia de las 
Naciones  Unidas sobre Comercio y Desarrollo (UNCTAD) en una comunicación de fecha 30 de agosto 
de 2022. 
 
_______________  
 
 
1  INTRODUCCIÓN  
1.  La secretaría de la UNCTAD, a través de su Dependencia de Propiedad Intelectual, adscrita  
a la División de la Inversión y la Empresa, lleva a cabo un programa para promover la dimensión  
de desarrollo de los derechos de propiedad intelectual . Teniendo en cuenta las iniciativas 
internacionales y regionales, como las de la Organización Mundial de la Propiedad Intelectual (OMPI) 
y de la Organización Mundial de la Salud (OMS), y el mandato establecido en el Pacto de Georgetow n 
de 2021, la UNCTAD se centra en mejorar la participación efectiva de los países en desarrollo en la 
elaboración de normas internacionales sobre propiedad intelectual, mejorar las políticas nacionales 
de propiedad intelectual y promover la cooperación reg ional en materia de derechos de propiedad 
intelectual . Asimismo, trabaja para reforzar la coherencia entre las políticas de propiedad intelectual, 
de inversión y comerciales a fin de alcanzar los Objetivos de Desarrollo Sostenible, abordar los 
cambios que traen consigo las tecnologías de frontera y reforzar la capacidad productiva en sectores 
vitales de las economías de los países en desarrollo, dando prioridad a los sectores farmacéutico y 
de vacunas . El programa de trabajo está financiado en parte por Gob iernos e instituciones donantes . 
Actualmente, el programa de trabajo se centra en la asistencia técnica y la creación de capacidad 
en ámbitos relacionados con 1)  la producción local de productos farmacéuticos y vacunas, en 
particular en el marco de la COVI D-19 y de la resistencia a los antimicrobianos (RAM), 2) las políticas 
regionales y nacionales sobre propiedad intelectual, y 3) la función de la propiedad intelectual en las 
asociaciones de tecnología e investigación y desarrollo.  
   
  IP/C/R/TC/UNCTAD/3  
- 2 - 
 
ANEXO1 
Name of programme or project  Addressing national investment incentives for local production of essential antibiotics  
Date and end date  1 July 2021 - 30 June 2022  
Beneficiary Member(s) or observer(s)  Ethiopia; Kenya; Uganda  
Brief description  Whereas globally there is an urgent need to develop new antibiotics to tackle antimicrobial resistance (AMR), in 
many developing countries the use and availability of existing antibiotics needs equal attention in order to improve 
access to and stewardship of antibiotics. In this conte xt, UNCTAD undertook national studies and organized 
webinars on investment incentives for local production of essential antibiotics in Uganda on 21 July 2021; Ethiopia 
on 8 September 2021 and Kenya on 13 October 2021. The webinars were organized in collabo ration with the 
government agencies responsible for health and industry with a view to validate the findings and 
recommendations of the national studies on local production of antibiotics and their alignment with the efforts to 
tackle AMR. The broad object ive of the programme is to develop better incentive regimes for domestic 
pharmaceutical firms to maintain a diverse portfolio of essential antibiotics in the market in a manner supportive 
of the policies to control AMR. The technical assistance programme f or the three countries will continue until June 
2023 with the financial support from the United Nations Development Account and in partnership with WHO and 
United Nations Economic Commission for Africa (UNECA).  
Beneficiary institution or audience  Policy m akers and regulatory agencies responsible for public health, national strategies to tackle AMR, investment 
and industry, representatives of pharmaceutical industry, civil society and academia.  
Technical cooperation provider(s)  UNCTAD  
Outputs or impact  1. Successful capacity building of national stakeholders on the need for the alignment of policies to combat 
AMR and to promote an incentive framework for local production of antibiotics;  
2. Identification of gaps and strength in the current national polic ies and incentives for pharmaceutical sector 
development; and  
3. Consensus building on key intervention areas to expand existing local productive capacity in essential 
antibiotics.  
Website for further information  https://unctad.org/project/investment -incentives -local-production -essential -antibiotics -east-africa  
Contact point for further information  Ermias Tekeste Biadgleng, Legal Affairs Officer, Intellectual Property Unit, UNCTAD. E -mail: 
ermias.biadgleng@un.org  
 
 
1 En inglés solamente.    
  IP/C/R/TC/UNCTAD/3  
- 3 - 
 
Name of programme or project  Addressing investment incentives for production and supply of  essential antibiotics at regional level 
(East African Community)  
Date and end date  1 July 2021 - 31 July 2022  
Beneficiary Member(s) or observer(s)  Burundi; Kenya; Rwanda; South Sudan; Tanzania; Uganda  
Brief description  In addition to its work at national level, UNCTAD is supporting the East African Community (EAC) to build regional 
level cooperation for the production and supply of antibiotics. In this context, UNCTAD undertook a study for 
regional cooperation; organized  a series of national consultative meetings (virtually or in hybrid) in each of the 
EAC partner states from 26 July to 6 August 2021; and held a regional validation workshop during the 2nd 
Regional meeting of the Taskforce on Procurement of Pharmaceutical Products of EAC on 10 November 2021. For 
the regional work programme in 2021 and 2022, UNCTAD partnered with the East African regional support 
programme of Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) in order to facilitate the national 
consultative meetings and the regional workshop. The technical assistance programme for EAC will continue until 
June 2023 with the financial support from the United Nations Development Account and in partnership with EAC 
Secretariat, UNECA and WHO.  
Benefic iary institution or audience  Representatives of health, industry and investment policy makers and regulators of EAC partner states and focal 
points for regional cooperation.  
Technical cooperation provider(s)  UNCTAD  
Outputs or impact  1. Improved understanding of policies to tackle AMR and incentives for production of antibiotics;  
2. Consensus building on the need for reginal cooperation, including information exchange on supply of 
antibiotics; and  
3. A regional decision for the (i) subst antive development and implementation of a regional policy framework 
to promote investment into antibiotics production; (ii) operationalizing information exchange among partner 
states on antibiotics that experience shortage for potential cooperation on poo led procurement; and (iii) the 
development regional cooperation on AMR.  
Website for further information  https://unctad.org/project/investment -incentives -local-production -essential -antibiotics -east-africa  
Contact point for further inf ormation  Ermias Tekeste Biadgleng, Legal Affairs Officer, Intellectual Property Unit, UNCTAD. E -mail: 
ermias.biadgleng@un.org  
   
  IP/C/R/TC/UNCTAD/3  
- 4 - 
 
Name of programme or project  Pandemic preparedness beyond COVID -19: Investing in vaccines production and supply for LMICs  
Date and end date  21 October 2021 - 21 October 2021  
Beneficiary Member(s) or observer(s)  Albania; Algeria; Antigua and Barbuda; Argentina; Armenia; Azerbaijan; Bahamas; Kingdom of Bahrain; 
Barbados; Belarus; Belize; Plurinational State of Bolivia; Bosnia and Herzegovina; Botswana; Brazil; Brunei 
Darussalam; Cabo Verde; Cameroon; Chile; China; Colombia; Congo; Costa Rica; Côte d'Ivoire; Cuba; Curaçao; 
Dominica; Dominican Republic; Ecuador; Egypt; El Sa lvador; Equatorial Guinea; Eswatini; Fiji; Gabon; Georgia; 
Ghana; Grenada; Guatemala; Guyana; Honduras; Hong Kong, China; India; Indonesia; Iran; Iraq; Israel; 
Jamaica; Jordan; Kazakhstan; Kenya; Republic of Korea; the State of Kuwait; Kyrgyz Republic; Leb anese 
Republic; Libya; Macao, China; Malaysia; Maldives; Mauritius; Mexico; Republic of Moldova; Mongolia; 
Montenegro; Morocco; Namibia; Nicaragua; Nigeria; North Macedonia; Oman; Pakistan; Panama; Papua New 
Guinea; Paraguay; Peru; Philippines; Qatar; Russ ian Federation; Saint Kitts and Nevis; Saint Lucia; Saint Vincent 
and the Grenadines; Samoa; Kingdom of Saudi Arabia; Serbia; Seychelles; Singapore; South Africa; Sri Lanka; 
Suriname; Syrian Arab Republic; Chinese Taipei Tajikistan; Thailand; Tonga; Trinid ad and Tobago; Tunisia; 
Türkiye; Turkmenistan; Ukraine; United Arab Emirates; Uruguay; Uzbekistan; Vanuatu; Bolivarian Republic of 
Venezuela; Viet Nam; Zimbabwe  
Brief description  UNCTAD organized a webinar on investing in vaccines production capacity in low - and middle -income countries 
(LMICs) in partnership with WHO as part of the 7th World Investment Forum, 2021. The objective of the webinar 
was to take stock of the existing international partnerships and initiatives, including the gaps and the means for 
further cooperation to building vaccines production capacity in LMICs. During the webinar, key global and strategic 
players came together to discuss the progress so far and exchange views on the way forward.   
Beneficiary institution or audie nce Development partners, regional organizations, national governments, private sector and civil society.  
Technical cooperation provider(s)  UNCTAD and WHO. The panellists included representatives of European Commission, Africa CDC, Coalition for 
Epidemic Preparedness Innovations (CEPI), African Vaccine Manufacturing Initiative (AVMI), African Development 
Bank (AfDB), Bill & Melinda Gates Foundation (BMGF), GIZ, and United Nations Economic Commission for Africa 
(UNECA).  
Outputs or impact  Panellists reviewe d the progress so far under the various initiatives, including that of the COVAX Manufacturing 
Task Force, the Partnerships for African Vaccine Manufacturing (PAVM), Coalition for Epidemic Preparedness 
Innovations (CEPI), the European Union, Africa Develop ment Bank (AfDB), Bill & Melinda Gates Foundation 
(BMGF), German Agency for International Cooperation (GIZ), among others. They have identified the successes 
of the global initiatives, including the mobilization of resources, collection of data on existing  productive capacity, 
establishment of the mRNA hub in South Africa and various investment initiatives for vaccines production. Many 
of the panellists expressed that a viable international cooperation is taking shape. There are, however, important 
areas th at require additional global effort, including market shaping, strengthening regulatory capacity and 
partnerships to promote development of products and new vaccine technologies.  
Website for further information  https://worldinvestmentforum.unctad.org/session/pandemic -preparedness -beyond -covid-19/ 
Contact point for further information  Ermias Tekeste Biadgleng, Legal Affairs Officer, Intellectual Property Unit, UNCTAD. E -mail: 
ermias.biadgleng@un.org  
   
  IP/C/R/TC/UNCTAD/3  
- 5 - 
 
Name of programme or project  Advisory services on technology transfer and intellectual property enablement for vaccines 
manufacturing  
Date and end date  1 July 2021 - 31 May 2022  
Beneficiary Member(s) or observer(s)  Algeria; Angola; Benin; Botswana; Burkina Faso; Burundi; Cabo Verde; Cameroon; Central African Republic; 
Chad; Comoros; Congo; Côte d'Ivoire; Democratic Republic of the Congo; Djibouti; Egypt; Equatorial Guinea; 
Eswatini; Ethiopia; Gabon; The Gambia; Ghana; Guinea; Guinea -Bissau; Kenya; Lesotho; Liberia; Libya; 
Madag ascar; Malawi; Mali; Mauritania; Mauritius; Morocco; Mozambique; Namibia; Niger; Nigeria; Rwanda; Sao 
Tomé and Principe; Senegal; Seychelles; Sierra Leone; Somalia; South Africa; South Sudan; Sudan; Tanzania; 
Togo; Tunisia; Uganda; Zambia; Zimbabwe  
Brief description  UNCTAD participated as an expert in the technology and intellectual property workstream of the Partnerships for 
African Vaccine Manufacturing (PAVM) from July 2021 to April 2022. UNCTAD provided technical advice on 
bottlenecks and solutions for  technology transfer, modalities and experience for successful technology transfer 
and cooperation on IP rights to build vaccines manufacturing capacity.  
Beneficiary institution or audience  Africa Centres for Disease Control and Prevention (Africa CDC) an d African Union  
Technical cooperation provider(s)  UNCTAD and other development partners  
Outputs or impact  UNCTAD's work contributed to the development of the Africa CDC's Framework for Action (FFA) under the 
Partnerships for African Vaccine Manufacturing  (PAVM).  
Website for further information  https://africacdc.org/download/partnerships -for-african -vaccine -manufacturing -pavm-framework -for-action/  
Contact point for further information  With respect to UNCTAD's work the contact person is Ermias Tekeste Biadgleng, Legal Affairs Officer, Intellectual 
Property Unit, UNCTAD. He can be reached at ermias.biadgleng@un.org  
 
Name of programme or project  Technical advice on regional cooperation for pharmaceutical sector development  
Date and end date  10 November 2021 - 10 November 2021  
Beneficiary Member(s) or observer(s)  Burundi; Kenya; Rwanda; South Sudan; Tanzania; Uganda  
Brief description  UNCTAD provided technical advice on regional cooperation for the development of pharmaceutical sector during 
the technical meeting of East African Legislative Assembly (EALA) general purpose committee on Pharmaceutical 
Bill that took plac e from 11 -13 November 2021. UNCTAD highlighted the pillars for regional cooperation, including, 
the removal of barriers to trade in pharmaceuticals and their intermediaries, free movement of skilled labour, 
movement of capital and service providers, region al exhaustion of IP rights, as well as regional approach to 
pharmaceutical registration, marketing approval and control of substandard products.   
Beneficiary institution or audience  Members of the East African Legislative Assembly (EALA) general purpose c ommittee for consideration of the 
draft East African Community (EAC) Pharmaceutical Bill.  
Technical cooperation provider(s)  UNCTAD  
Outputs or impact  General awareness on the scope of regional cooperation and direct input to a regional legislative process to 
support pharmaceutical sector development.  
Website for further information   
Contact point for further information  Ermias Tekeste Biadgleng, Legal Affairs Officer, Intellectual Property Unit, UNCTAD. E -mail: 
ermias.biadgleng@un.org    
  IP/C/R/TC/UNCTAD/3  
- 6 - 
 
 
Name of programme or project  Capacity building and advisory services on regional cooperati on on intellectual property rights  
Date and end date  1 July 2020 - 30 December 2022  
Beneficiary Member(s) or observer(s)  Algeria; Angola; Benin; Botswana; Burkina Faso; Burundi; Cabo Verde; Cameroon; Central African Republic; 
Chad; Comoros; Congo; Côte d'Ivoire; Democratic Republic of the Congo; Djibouti; Egypt; Equatorial Guinea; 
Eswatini; Ethiopia; Gabon; The Gambia; Ghana; Guinea; Guinea -Bissau; Kenya; Lesotho; Liberia; Libya; 
Madagascar; Malawi; Mali; Mauritania; Mauritius; Morocco; Mozambique; Namibia; Niger; Nigeria; Rwanda; Sao 
Tomé and Principe; Senegal; Seychelles; Sierra Leone; Somalia; South Africa; South Sudan; Sudan; Tanzania; 
Togo; Tunisia; Uganda; Zambia; Zimbabwe  
Brief description  UNCTAD 's IP unit has been providing technical advice on reginal cooperation on IP rights in the context of the 
negotiation for IP rights Protocol under the African Continental Free Trade Area (AfCFTA). During this reporting 
period, UNCTAD provided training for IP rights negotiators on IP rights in general, t he international system for 
the protection of IP rights and the potential approaches for regional cooperation during the 1st and 2nd meetings 
of the AfCFTA Committee on Intellectual Property Rights. UNCTAD made presentations and facilitated discussions 
among regional stakeholders during consultations organized by the AfCFTA Secretariat for Southern and Eastern 
Africa Region on 2 March 2022, Western and Central Africa Region on 3 March 2022 and Northern Africa Region 
on 4 March 2022. The consultations were c entred around identifying potential scope and the approach to a 
regional protocol on IP rights.   
Beneficiary institution or audience  AfCFTA negotiators, representatives of business associations, academia, civil society organizations, African IP 
rights organizations and associations, individual entrepreneurs, and government institutions.  
Technical cooperation provider(s)  UNCTAD and AfCFTA Secretariat  
Outputs or impact  1. Successful collection of the views and recommendations of regional stakeho lders on the scope and the approach 
to a regional protocol on IP rights; and  
2. Development of modalities and preliminary list of issues for regional IP rights protocol.  
Website for further information   
Contact point for further information  Ermias Tekeste Biadgleng, Legal Affairs Officer, Intellectual Property Unit, UNCTAD. E -mail: 
ermias.biadgleng@un.org  
   
  IP/C/R/TC/UNCTAD/3  
- 7 - 
 
Name of programme or project  Intellectual property and public health: Case law database  
Date and end date  1 June 2020 - 31 July 2022  
Beneficiary Member(s) or observer(s)  Albania; Algeria; Antigua and Barbuda; Argentina; Armenia; Azerbaijan; Bahamas; Kingdom of Bahrain; 
Barbados; Belarus; Belize; Plurinational State of Bolivia; Bosnia and Herzegovina; Botswana; Brazil; Brunei 
Darussalam; Cabo Verde; Cameroon; Chile; China; Colombia; Congo; Costa Rica; Côte d'Ivoire; Cuba; Curaçao; 
Dominica; Dominican Republic; Ecuador; Egypt; El Salvador; Equatorial Guinea; Eswatini; Fiji; Gabon; Georgia; 
Ghana; Grenada; Guatemala; Guyana; Honduras; Hong Kong, China; India; Indonesia; Iran; Iraq; Israel; 
Jamaica; Jordan; Kazakhstan; Kenya; Republic of Korea; the State of Kuwait; Kyrgyz Republic; Lebanese 
Republic; Libya; Macao, China; Malaysia; Maldives; Mau ritius; Mexico; Republic of Moldova; Mongolia; 
Montenegro; Morocco; Namibia; Nicaragua; Nigeria; North Macedonia; Oman; Pakistan; Panama; Papua New 
Guinea; Paraguay; Peru; Philippines; Qatar; Russian Federation; Saint Kitts and Nevis; Saint Lucia; Saint Vi ncent 
and the Grenadines; Samoa; Kingdom of Saudi Arabia; Serbia; Seychelles; Singapore; South Africa; Sri Lanka; 
Suriname; Syrian Arab Republic; Chinese Taipei; Tajikistan; Thailand; Tonga; Trinidad and Tobago; Tunisia; 
Türkiye; Turkmenistan; Ukraine; Uni ted Arab Emirates; Uruguay; Uzbekistan; Vanuatu; Bolivarian Republic of 
Venezuela; Viet Nam; Zimbabwe  
Brief description  UNCTAD has developed a case law database consisting of a systematic collection of the summaries of notable 
judgments adopted by nationa l or regional judicial organs of the members of the World Trade Organization (WTO).  
During the reporting period, UNCTAD updated the database with additional summaries. The case law database 
continues to be used by independent researchers and technical assi stance providers.  
Beneficiary institution or audience  Judicial organs, policy makers and researchers.  
Technical cooperation provider(s)  UNCTAD  
Outputs or impact  Increased opportunity for learning and information exchange among the judicial organs, polic y makers and 
researchers of WTO member countries on IP rights in the context of public health.  
Website for further information  https://unctad.org/ippcaselaw/  
Contact point for further information  Ermias Tekeste Biadgleng, Legal Affairs Officer, Intellectual Property Unit, UNCTAD. E -mail: 
ermias.biadgleng@un.org  
   
  IP/C/R/TC/UNCTAD/3  
- 8 - 
 
Name of programme or project  Partnership for capacity building and technical assistance on IP rights and sustainable development  
Date and end date  1 July 2021 - 30 June 2022  
Beneficiary Member(s) or observer(s)  Albania; Algeria; Antigua and Barbuda; Argentina; Armenia; Azerbaijan; Bahamas; Kingdom of Bahrain; 
Barbados; Belarus; Belize; Plurinational State of Bolivia; Bosnia and Herzegovina; Botswana; Brazil; Brunei 
Darussalam; Cabo Verde; Cameroon; Chile; China; Colombia; Congo; Costa Rica; Côte d'Ivoire; Cuba; Curaçao; 
Dominica; Dominican Republic; Ecuador; Eg ypt; El Salvador; Equatorial Guinea; Eswatini; Fiji; Gabon; Georgia; 
Ghana; Grenada; Guatemala; Guyana; Honduras; Hong Kong, China; India; Indonesia; Iran; Iraq; Israel; 
Jamaica; Jordan; Kazakhstan; Kenya; Republic of Korea; the State of Kuwait; Kyrgyz Rep ublic; Lebanese 
Republic; Libya; Macao, China; Malaysia; Maldives; Mauritius; Mexico; Republic of Moldova; Mongolia; 
Montenegro; Morocco; Namibia; Nicaragua; Nigeria; North Macedonia; Oman; Pakistan; Panama; Papua New 
Guinea; Paraguay; Peru; Philippines; Q atar; Russian Federation; Saint Kitts and Nevis; Saint Lucia; Saint Vincent 
and the Grenadines; Samoa; Kingdom of Saudi Arabia; Serbia; Seychelles; Singapore; South Africa; Sri Lanka; 
Suriname; Syrian Arab Republic; Chinese Taipei; Tajikistan; Thailand; To nga; Trinidad and Tobago; Tunisia; 
Türkiye; Turkmenistan; Ukraine; United Arab Emirates; Uruguay; Uzbekistan; Vanuatu; Bolivarian Republic of 
Venezuela; Viet Nam; Zimbabwe  
Brief description  UNCTAD 's IP Unit collaborated with various organizations and deve lopment partners to provide capacity building 
and advisory services on IP rights, pharmaceutical sector development and access to medicines. These include, 
among several others, contributions to:  
1. During the session on local production of medicines at th e joint UNFPA -UNICEF -WHO meeting, that took 
place virtually from 8 -10 March 2022;  
2. The virtual inter -agency pharmaceutical coordination group meeting held by the WHO on 16 December 
2021;  
3. Regional judges training for Africa, March 2022; and training for judges and competition authorities of 
Thailand held in March and May 2022 by the South Centre;  
4. WIPO 's coordination meeting with IGOs working in the area of building respect for IP, June 21, 2022; and  
5. Technical assistance to Ghana on vaccines prod uction implemented by GIZ -Ghana throughout the 
reporting period.  
Beneficiary institution or audience  Diverse group of stakeholders representing development partners, private sector, domestic institutions of 
countries, and civil society.  
Technical cooper ation provider(s)  UNCTAD in partnership with other organizations.  
Outputs or impact  Strengthening partnership for technical assistance, capacity bundling, advisory services and consensus building 
on IP rights, pharmaceuticals and access to medicines.  
Website for further information   
Contact point for further information  Ermias Tekeste Biadgleng, Legal Affairs Officer, Intellectual Property Unit, UNCTAD. E -mail: 
ermias.biadgleng@un.org  
 
__________